Preliminary chemical profile and in vitro pharmacological evaluation of the hallucinogenic plant Diplopterys cabrerana
DOI:
https://doi.org/10.48797/sl.2024.221Keywords:
PosterAbstract
Background: For the last few years, Ayahuasca ceremonies have been gaining popularity in recreational settings in Europe and North America [1]. Similar to Psychotria viridis, Diplopterys cabrerana is also suggested to contain the psychoactive compound N,N-dimethyltryptamine, and is therefore used in Ayahuasca rituals for its ability to induce hallucinations, euphoria and entheogenic effects [1-3]. However, while information on the toxic profile of D. cabrerana remains very limited, its acquisition is easily accomplished by consumers. Objective: We aimed to characterize the aqueous extracts of D. cabrerana leaves, mimicking those typically consumed, to identify bioactives that underlie the psychoactive or toxic effects, and evaluate their impact on neuronal function, neurotransmission and radical stress. Methods: Chemical characterization was attained by HPLC-DAD. Impact upon neuronal viability was assessed by the MTT assay (up to 1000 µg/mL) in SH-SY5Y neuroblastoma cells. Impact on neuromodulation and neuroinflammation was evaluated through acetylcholinesterase and 5-lipoxygenase inhibition, while antiradical properties were assessed by evaluating nitric oxide (•NO) and xanthine oxidase (XO) activity. Inhibition of the α-glucosidase enzyme was also evaluated. Statistical comparisons among groups performed by one-way ANOVA followed by Dunnett post hoc test. Results: Preliminary characterization results revealed the presence of several catechin derivates, alongside two apigenin derivates and one tryptamine derivate. Cytotoxicity was not verified up to the highest concentration tested. Acetylcholinesterase inhibition was recorded starting at 250 µg/mL, and a concentration-dependent inhibition of 5-lipoxygenase was found (IC50=79.77 µg/mL). Concentration-dependent scavenging effects upon •NO and XO inhibition were verified at concentrations higher than 1.953 µg/mL and 31.25 µg/mL, respectively. At last, inhibition of α-glucosidase occurred with concentration-dependency and an IC50 of 4.78 µg/mL. Conclusions: Although antiradical, anti-inflammatory and antidiabetic properties were verified, with no in vitro cytotoxicity being detected, further research is needed to elucidate the underlying mechanisms that might be involved in our preliminary results.
References
1. Hamill, J. et al. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addic-tion and Mental Illness. Current neuropharmacology. (2019) 17, 108–128.
2. Goldin D, Salani D. Ayahuasca: What Healthcare Providers Need to Know. J Addict Nurs. (2021) 32, 167-173.
3. Brito-da-Costa, AM. et al. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact. Pharmaceuticals (Basel). (2020) 13, 334.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Maria Rita Garcia, Mykhaylo Dutka, Sofia Guimarães, Paula B. Andrade, Vítor Seabra, Diana Dias-da-Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
In Scientific Letters, articles are published under a CC-BY license (Creative Commons Attribution 4.0 International License), the most open license available. The users can share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as they give appropriate credit, provide a link to the license, and indicate if changes were made (read the full text of the license terms and conditions of use).
The author is the owner of the copyright.